Xynomic Pharmaceuticals Holdings, Inc. Warrant
XYNPW
XYNPW was delisted on the 16th of July, 2019.
1 hedge funds and large institutions have $5K invested in Xynomic Pharmaceuticals Holdings, Inc. Warrant in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 10 closing their positions.
92% less funds holding
Funds holding: 12 → 1 (-11)
97% less capital invested
Capital invested by funds: $184K → $5K (-$179K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 10
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$50K |
| 2 |
VAS
VR Advisory Services
Camana Bay, Grand Cayman,
Cayman Islands
|
-$28K |
| 3 |
ICM
Ionic Capital Management
New York
|
-$21K |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$16K |
| 5 |
Walleye Trading
New York
|
-$14K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
1
Context Capital Management
Lajolla,
California
| $5K | – | – | – |
|
|
PAMP
2
Polar Asset Management Partners
Toronto,
Ontario, Canada
| – | -$50K | -236,873 | Closed |
|
|
VAS
3
VR Advisory Services
Camana Bay, Grand Cayman,
Cayman Islands
| – | -$28K | -134,748 | Closed |
|
|
ICM
4
Ionic Capital Management
New York
| – | -$21K | -101,533 | Closed |
|
|
AA
5
AQR Arbitrage
Greenwich,
Connecticut
| – | -$16K | -75,000 | Closed |
|
|
6
Walleye Trading
New York
| – | -$14K | -67,211 | Closed |
|
|
6CM
7
683 Capital Management
New York
| – | -$11K | -50,000 | Closed |
|
|
BI
8
Bulldog Investors
Saddle Brook,
New Jersey
| – | -$11 | -50,000 | Closed |
|
|
YCM
9
Yakira Capital Management
Westport,
Connecticut
| – | -$11K | -50,000 | Closed |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| – | -$5K | -24,703 | Closed |
|
|
PC
11
Periscope Capital
Toronto,
Ontario, Canada
| – | -$4K | -20,300 | Closed |
|
XYNPW Hedge Fund Activity: Q3 2019 in Review
1 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Xynomic Pharmaceuticals Holdings, Inc. Warrant (XYNPW) for Q3 2019, worth a combined $5K — down 97% from $184K a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of XYNPW and 0 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $50K sold.
- 1 institutional investor held Xynomic Pharmaceuticals Holdings, Inc. Warrant (XYNPW) as of Q3 2019, down from 12 in Q2 2019.
- Funds reported $5K of Xynomic Pharmaceuticals Holdings, Inc. Warrant stock for Q3 2019, down 97% quarter-over-quarter.
- 0 funds opened new Xynomic Pharmaceuticals Holdings, Inc. Warrant positions in Q3 2019 and 10 closed out, a net change of -10 holders.
- The largest Xynomic Pharmaceuticals Holdings, Inc. Warrant seller in Q3 2019 was Polar Asset Management Partners, an estimated $50K sold.
Based on aggregated 13F filings for Q3 2019.